Commercialization of Early Detection Technologies for Epileptic Seizures 

Explore, Research

AI-Neotech, a spinoff company of Dr. Fahad Saeed, has been awarded a Small Business Technology Transfer (STTR) grant to explore the commercialization of technology invented at KFSCIS leading to the detection of oncoming epileptic seizures. The company will explore the development of a patient-specific system for early detection and identification of epileptic seizures and lead commercialization to put the technology in the marketplace.

With more than 3 million adults and 1 million children in the US, and more than 50 million people worldwide suffering from epilepsy, repeated and unpredictable seizures significantly affect their quality of life. If the company is successful, it will be able to provide epileptic patients, and their caregivers a smart system that can predict seizures before they occur. Repeated and unpredictable seizures significantly affect the quality of life of people suffering from epilepsy. These seizures remain the leading cause of economic, emotional, and physical injuries for people with epilepsy and their caregivers. Design, development, and integration of artificial intelligence (AI) models with instruments that detect abnormalities in brain waves like an electroencephalogram (EEG) for real-time seizure prediction may bring improvements for these patients and their caregivers.

The full abstract of the project award can be found at

Read the full article posted on FIU News here: